Drugs / Group T
last change Jul 2015 re-read 3 minutes ago

Group T

Developed for
meningitis
Investigated by
Beijing Minhai Biotechnology Co., Ltd

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02003313 Nov 2013 → May 2015 meningitis Beijing Minhai Biotechnology Co., Ltd Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Group T ClinicalTrials.gov intervention name — accepted as the source's own label NCT02003313 ↗